Cargando…
Developmental protein HOXC11 cooperates with SRC-1 in breast cancer: an adaptive response to endocrine therapy
Autores principales: | McIlroy, M, McCartan, D, Early, S, Pennington, S, O'Gaora, P, Hill, A, Young, L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875583/ http://dx.doi.org/10.1186/bcr2518 |
Ejemplares similares
-
Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer
por: Ali, Azlena, et al.
Publicado: (2015) -
HOXC11–SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib
por: deBlacam, C, et al.
Publicado: (2011) -
Protein bomarkers Ki67, HOXC10 and HOXC11 for the prediction of response to endocrine treatment in breast cancer
por: Soon, YH, et al.
Publicado: (2015) -
Mental Health in Northern Ireland—Laws Ancient and Modern
por: McCartan, William
Publicado: (1963) -
The Use of Split-Thickness Skin Grafts on Diabetic Foot Ulcerations: A Literature Review
por: McCartan, Brant, et al.
Publicado: (2012)